The scientific community has been alarmed by the possible immunological evasion, higher
infectivity, and severity of disease caused by the newest variants of SARS-CoV-2. The spike …

Objectives The spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
virus has been unprecedentedly fast, spreading to more than 180 countries within 3 months …

Abstract Late in 2019, SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2)
emerged, causing an unknown type of pneumonia today called coronaviruses disease 2019 …

The COVID-19 pandemic worldwide has resulted in over 176 million cases and roughly 3.8
million deaths so far. We could analyze mutation dynamics across the genome from …

A novel coronavirus (SARS-CoV-2) emerged towards the end of 2019 that caused a severe
respiratory disease in humans called COVID-19. It led to a pandemic with a high rate of …

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
become the main target for antiviral and vaccine development. Despite its relevance, e …

Here we report a preliminary genomic analysis of SARS-CoV-2 B. 1.1. 28 lineage circulating
in the Brazilian Amazon region and their evolutionary relationship with emerging and …

Abstracts Despite the rising natural and vaccines mediated immunity, several countries have
experienced a resurgence of the Coronavirus disease of 2019 (COVID-19) due to the …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Brazil was
dominated by two lineages designated as B. 1.1. 28 and B. 1.1. 33. The two SARS-CoV-2 …

The SARS-CoV-2 spike protein mediates target recognition, cellular entry, and ultimately the
viral infection that leads to various levels of COVID-19 severities. Positive evolutionary …